AI-generated summary
The authors studied 15 chronic poststroke patients with upper-limb spasticity in a double-blind, placebo-controlled trial of 808 nm photobiomodulation with and without exoskeleton-assisted treatment. They report increased elbow range of motion after photobiomodulation and increased muscle signal (RMS) after photobiomodulation plus exoskeleton, with the 12 healthy volunteers used only for evaluation.
- Participants
- 15
- Who or what was studied
- Chronic hemiparetic poststroke patients with upper-limb (biceps) spasticity, plus 12 healthy volunteers
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes a small sample and does not report a comparison of the effect sizes between the treatment phases, so the findings should be read as preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 159.24 J/cm2
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Placebo-controlled, Laser, Low-level laser therapy, Near-infrared, Photobiomodulation, Stroke. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.